Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.
Rinaldi F, Perini P, Atzori M, Favaretto A, Seppi D, Gallo P
Mult Scler Int. 2015; 2015:369348. Epub 2015 Feb 23. PMID: 25802758.Abstract
